Form D · Pharmaceuticals
MANNKIND CORP
Valencia, CA · CIK 0000899460
Offering snapshot reported Jul 15, 2013 · SEC filing
- Reported sold
- $58.9M Offering amount: $179M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 1, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 15, 2013 | Initial | $58,900,000 | No comparison | 2 | SEC filing |
| Aug 17, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-199697
Rights to receive cash payments upon the occurrence of certain milestone events.
Source: Form D, filed Jul 15, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ronald Consiglio | Director |
| Hakan S Edstrom | Director, Executive |
| Michael Friedman | Director |
| Kent Kresa | Director |
| David H Maccallum | Director |
| Alfred E Mann | Director, Executive |
| Juergen A Martens | Executive |
| Henry L Nordhoff | Director |
| Diane M Palumbo | Executive |
| Matthew J Pfeffer | Executive |
| David B Thomson | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
28903 North Avenue Paine
Valencia, CA, 91355
Valencia, CA, 91355